cro.directory
← Compare landing

Accelevir vs Precision for Medicine

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/accelevirdx/precision-for-medicine

CategoryAccelevirPrecision for Medicine
Listed sitecrocro
SummaryCLIA-certified CRO specializing in ultra-sensitive molecular analytics, custom immunology assays, and integrated virology-immunology workflows for cell therapies, gene editing, and infectious disease programs.Precision for Medicine combines clinical trial management, feasibility and site selection, clinical data management, and biostatistics with specialty lab work in flow cytometry, cytokine proteomics, and biomarker validation. Its cell and gene therapy and companion diagnostic offerings target sponsors developing advanced modalities.
Services
  • Virology Services
  • Immunology & Inflammation Services
  • Flow Cytometry Services
  • Genomics & Sequencing Services
  • Biomarker Assays
  • Translational Research
  • Clinical Trial Services
  • Central Laboratory Services
  • Clinical Operations
  • Clinical Trial Services
  • Central Laboratory Services
  • Data Management & eClinical
  • Pharmacovigilance & Drug Safety
  • Biostatistics & Statistical Programming
  • Medical Writing
  • Regulatory Affairs
  • Flow Cytometry Services
  • Proteomics Services
  • Genomics & Sequencing Services
  • Bioanalysis
  • Biomarker Assays
  • Translational Research
  • Companion Diagnostics Development
Modalities
  • Gene Therapy
  • Cell Therapy
  • Vaccine
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Indications
  • Oncology
  • Immunology
  • Infectious Disease
Data not yet provided.
Locations
  • Headquarters, Maryland, Maryland, United States
Data not yet provided.
Certifications
  • CLIA · Identifier: CLIA-certified
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.